Bioventus (BVS) Total Liabilities (2020 - 2026)
Bioventus' (BVS) quarterly Total Liabilities came in at $416.3 million in Q1 2026, down 17.72% YoY from $505.9 million in Q1 2025, and down 8.53% on a QoQ basis from $455.1 million in Q4 2025.
Bioventus (BVS) Total Liabilities (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Total Liabilities data on file, last reported at $416.3 million in Q1 2026.
- Quarterly Total Liabilities fell 17.72% year-over-year to $416.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $416.3 million (down 17.72% YoY) and the FY2025 annual result came in at $455.1 million, down 16.09% from the prior year.
- Total Liabilities eased to $416.3 million in Q1 2026, from $455.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.0 billion in Q4 2022 to a low of $416.3 million in Q1 2026.
- A 5-year average of $614.7 million and a median of $584.6 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 140.14% — and 2023, when it sank 42.62%.
- Tracing BVS's Total Liabilities over 5 years: stood at $960.4 million in 2022, then slumped by 38.59% to $589.8 million in 2023, then retreated by 8.04% to $542.4 million in 2024, then dropped by 16.09% to $455.1 million in 2025, then retreated by 8.53% to $416.3 million in 2026.
- The last three Total Liabilities figures came in at $416.3 million (Q1 2026), $455.1 million (Q4 2025), and $494.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Bioventus | 970.53 Mn | 941.07 Mn | 105.67 Mn | 395.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 395.93 Mn |
| Mar 28, 2026 | 416.27 Mn |
| Dec 31, 2025 | 455.11 Mn |
| Sep 27, 2025 | 494.34 Mn |
| Jun 28, 2025 | 505.49 Mn |
| Mar 29, 2025 | 505.94 Mn |
| Dec 31, 2024 | 542.35 Mn |
| Sep 28, 2024 | 582.66 Mn |
| Jun 29, 2024 | 603.11 Mn |
| Mar 30, 2024 | 576.81 Mn |
| Dec 31, 2023 | 589.79 Mn |
| Sep 30, 2023 | 584.65 Mn |
| Jul 1, 2023 | 603.62 Mn |
| Apr 1, 2023 | 647.04 Mn |
| Dec 31, 2022 | 960.43 Mn |
| Oct 1, 2022 | 1.02 Bn |
| Jul 2, 2022 | 688.59 Mn |
| Apr 2, 2022 | 675.22 Mn |
| Dec 31, 2021 | 618.21 Mn |
| Oct 2, 2021 | 424.29 Mn |